219 related articles for article (PubMed ID: 34771042)
1. Fabrication and Biological Assessment of Antidiabetic α-Mangostin Loaded Nanosponges: In Vitro, In Vivo, and In Silico Studies.
Usman F; Shah HS; Zaib S; Manee S; Mudassir J; Khan A; Batiha GE; Abualnaja KM; Alhashmialameer D; Khan I
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771042
[TBL] [Abstract][Full Text] [Related]
2. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats.
Taha M; Imran S; Salahuddin M; Iqbal N; Rahim F; Uddin N; Shehzad A; Khalid Farooq R; Alomari M; Mohammed Khan K
Bioorg Chem; 2021 May; 110():104808. PubMed ID: 33756236
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies.
Ihmaid S
Molecules; 2018 May; 23(6):. PubMed ID: 29844263
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
[TBL] [Abstract][Full Text] [Related]
6. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
Ye GJ; Lan T; Huang ZX; Cheng XN; Cai CY; Ding SM; Xie ML; Wang B
Eur J Med Chem; 2019 Sep; 177():362-373. PubMed ID: 31158750
[TBL] [Abstract][Full Text] [Related]
8. Anti-α-Glucosidase and Antiglycation Activities of α-Mangostin and New Xanthenone Derivatives: Enzymatic Kinetics and Mechanistic Insights through In Vitro Studies.
Djeujo FM; Francesconi V; Gonella M; Ragazzi E; Tonelli M; Froldi G
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056861
[TBL] [Abstract][Full Text] [Related]
9. Novel class of hybrid natural products as antidiabetic agents.
Raj K; Misra N; Pachauri G; Sharma M; Tamrakar AK; Singh AB; Srivastava AK; Phani Kiran K; Narasimha Rao CV; Prubhu SR
Nat Prod Res; 2009; 23(1):60-9. PubMed ID: 19140071
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors.
Aguila-Muñoz DG; Vázquez-Lira G; Sarmiento-Tlale E; Cruz-López MC; Jiménez-Montejo FE; López Y López VE; Escalante CH; Andrade-Pavón D; Gómez-García O; Tamariz J; Mendieta-Moctezuma A
Molecules; 2023 May; 28(10):. PubMed ID: 37241920
[TBL] [Abstract][Full Text] [Related]
11. Towards multi-target antidiabetic agents: In vitro and in vivo evaluation of 3,5-disubstituted indolin-2-one derivatives as novel α-glucosidase inhibitors.
Klochkov VG; Bezsonova EN; Dubar M; Melekhina DD; Temnov VV; Zaryanova EV; Lozinskaya NA; Babkov DA; Spasov AA
Bioorg Med Chem Lett; 2022 Jan; 55():128449. PubMed ID: 34780899
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
[TBL] [Abstract][Full Text] [Related]
13. Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ.
Chen SP; Lin SR; Chen TH; Ng HS; Yim HS; Leong MK; Weng CF
Biomed Pharmacother; 2021 Dec; 144():112333. PubMed ID: 34678724
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents.
Hu Y; Wang B; Yang J; Liu T; Sun J; Wang X
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):15-30. PubMed ID: 30362362
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory evaluation of
Zabidi NA; Ishak NA; Hamid M; Ashari SE; Mohammad Latif MA
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):109-121. PubMed ID: 33249946
[TBL] [Abstract][Full Text] [Related]
16. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
Zahra S; Zaib S; Khan I
Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
[TBL] [Abstract][Full Text] [Related]
17. Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents.
Tafesse TB; Bule MH; Khoobi M; Faramarzi MA; Abdollahi M; Amini M
Mini Rev Med Chem; 2020; 20(2):134-151. PubMed ID: 31553294
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, α-glucosidase inhibitory activity and in silico study of tris-indole hybrid scaffold with oxadiazole ring: As potential leads for the management of type-II diabetes mellitus.
Taha M; Rahim F; Imran S; Ismail NH; Ullah H; Selvaraj M; Javid MT; Salar U; Ali M; Khan KM
Bioorg Chem; 2017 Oct; 74():30-40. PubMed ID: 28750203
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors.
Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L
Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322
[TBL] [Abstract][Full Text] [Related]
20. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and
Bashir MA; Javaid K; Shaikh M; Choudhary MI; Siddiqui H
Med Chem; 2020; 16(8):1124-1135. PubMed ID: 32003674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
